INDRAPRASTHA MEDICAL CORP Share Price

INDRAPRASTHA MEDICAL CORP Share Price

NSE: INDRAMEDCO
|
Healthcare Services
₹ 364.60
-₹2.30 (-0.63%)
1D
Last updated 24 Jul, 2026, 15:59 IST

INDRAPRASTHA MEDICAL CORP Share Price Today

As of 25 Jul 2026, INDRAPRASTHA MEDICAL CORP share price is ₹364.60. The stock opened at ₹366.10, compared to its previous close of ₹366.90. During today's trading session, INDRAPRASTHA MEDICAL CORP share price moved in the range of ₹360.00 to ₹366.75, with an average price of ₹363.38 for the day. Looking at its last 52-week, the stock has touched a low of ₹342.00 and a high of ₹640.85. On the performance front, INDRAPRASTHA MEDICAL CORP share price has increased by 1.00% over the last six months and is down 22.17% on a year-on-year basis.

₹360.00
0.63% down today
₹366.75
1D LOW
1D HIGH

INDRAPRASTHA MEDICAL CORP Returns Calculator

Circuit
L
H
₹291.70
₹437.50
52-week
L
H
₹342.00
₹640.85
Mkt Cap Cr
3,338.73
P/E
18.31
P/B
4.54
ROE
24.80%
D/E
0.05
ROCE
32.39%
Div. Yield
1.09%
EPS(TTM)
20.03
Turnover
1.80
EV/EBITDA
10.63
Net Margin
0.00%
Op. Margin
0.00%
ROA
18.52%
Quick Ratio
0.00
Curr. Ratio
2.51
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Indrapr.Medical has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Indrapr.Medical appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,26,592.0063.7613.4820.48%0.3217.27%692.920.23%0.70103.81
Max Healthcare1,05,256.0064.898.7114.33%0.0813.72%10.470.21%0.287.37
Fortis Healthcare71,354.9057.586.0611.31%0.2213.36%6.500.13%0.163.05
Aster DM Healthcare68,387.10160.0014.928.48%0.3110.10%53.530.23%0.465.20
Narayana Hrudayalaya40,457.3050.208.9217.76%0.7611.42%127.100.23%0.8524.77
Global Health36,944.3066.679.3314.05%0.0615.26%149.240.04%0.7718.46
KRISHNA INST OF MED SCI L33,485.00138.418.9410.74%0.637.99%93.540.00%0.466.52
Dr. Lal Path Labs28,275.5043.618.7821.78%0.0727.45%8.901.56%1.0130.45
Poly Medicure16,538.8051.575.3210.37%0.0812.71%301.180.21%0.5333.15
Syngene International16,413.2049.653.257.78%0.059.52%3.340.32%0.677.58

INDRAPRASTHA MEDICAL CORP Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,356.36₹1,244.70₹1,098.67₹888.16
Other Income₹22.65₹16.89₹10.03₹3.12
Total Revenue₹1,379.01₹1,261.59₹1,108.70₹891.28
Total Expenses₹1,162.69₹1,095.48₹991.52₹812.21
Profit Before Tax₹216.32₹166.11₹117.18₹79.07
Tax₹55.33₹42.15₹31.03₹20.45
Profit After Tax₹160.99₹123.96₹86.15₹58.62
EPS - Basic₹17.56₹13.52₹9.40₹6.39
EPS - Diluted₹17.56₹13.52₹9.40₹6.39

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹216.32₹166.11₹117.18₹79.07
Income before WC changes₹241.54₹191.53₹147.75₹117.27
Change in Assets-₹18.82₹14.79-₹21.95₹24.70
Change in Liabilities-₹4.98₹40.67₹28.61-₹28.15
Change in WC-₹23.80₹55.46₹6.66-₹3.45
Cash flow from Operations₹156.75₹200.15₹144.47₹94.30
Cash flow from Investing-₹110.99-₹158.43-₹107.91-₹74.11
Cash flow from Financing-₹45.88-₹32.38-₹26.04-₹3.37
Total Cash Flow-₹0.12₹9.34₹10.52₹16.82
Cash (Start of the year)₹61.60₹52.26₹41.74₹24.92
Cash (End of the year)₹61.48₹61.60₹52.26₹41.74

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹420.49₹415.26₹332.06₹304.28
Current Assets₹431.13₹307.98₹223.08₹157.43
Total Assets₹851.62₹723.24₹555.14₹461.71
Current Liabilities₹178.71₹165.42₹129.63₹93.50
Net Current Asset₹252.42₹142.56₹93.45₹63.93
Non-Current Liabilities₹76.23₹80.06₹46.06₹42.77
Equity Capital₹596.68₹477.76₹379.45₹325.44
Total Equity & Liabilities₹851.62₹723.24₹555.14₹461.71
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
364.6
32
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 32
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
39.39
Neutral
ATR (14)
8.95
Neutral
STOCH(9,6)
19.39
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
32.23
Bearish
UO(9)
40.01
Neutral
ROC(12)
-3.15
Bearish
WillR(14)
-85.23
Bullish
Period
Simple value
Exponential vaue
5D
370.8
370.37
10D
373.88
373.16
20D
378.38
376.79
50D
379.49
383.46
100D
392.57
396.43

About INDRAPRASTHA MEDICAL CORP

INDRAPRASTHA MEDICAL CORP Share Price
ISIN
INE681B01017
Sector Market Cap
₹ 3,338.73 Cr

Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.

INDRAPRASTHA MEDICAL CORP Financial Highlights

  • Revenue: INDRAPRASTHA MEDICAL CORP reported revenue of ₹1,511.26 crore in FY26 vs ₹1,379.01 crore in FY25. It showed an increase of 9.59% on a yearly basis.
  • Operating Profit: INDRAPRASTHA MEDICAL CORP reported an operating profit of ₹246.02 crore in FY26 vs ₹216.32 crore in FY25. It showed an increase of 13.73% on a year-on-year basis.
  • Net Profit: INDRAPRASTHA MEDICAL CORP reported a net profit of ₹183.62 crore in FY26 vs ₹160.99 crore in FY25. It showed an increase of 14.06% on a yearly basis.

INDRAPRASTHA MEDICAL CORP Quarterly Result Highlights

  • INDRAPRASTHA MEDICAL CORP reported revenue of ₹372.14 crore in Mar 2026, compared with ₹378.76 crore in Dec 2025, representing a decrease of 1.75% on a quarter-on-quarter (QoQ) basis.
  • INDRAPRASTHA MEDICAL CORP reported an operating profit of ₹55.01 crore in Mar 2026, compared with ₹56.39 crore in Dec 2025, representing a decrease of 2.45% on a quarter-on-quarter (QoQ) basis.
  • INDRAPRASTHA MEDICAL CORP reported a profit of ₹41.70 crore in Mar 2026, compared with ₹41.00 crore in Dec 2025, reflecting an increase of 1.71% on a QoQ basis.
  • The earnings per share (EPS) of INDRAPRASTHA MEDICAL CORP stood at ₹17.56 during Mar 2026.
Know more
Promoters
51.00%
FII
2.77%
Other DII
0.57%
Retail and other
45.65%
Mutual funds
0.01%
Foreign institutions - FII
Compare against other stocks
INDRAPRASTHA MEDICAL CORP Share Price
INDRAPRASTHA MEDICAL CORP
Healthcare Services
Add Stock
Add Another

FAQs on INDRAPRASTHA MEDICAL CORP Share Price